Related references
Note: Only part of the references are listed.A Novel Transdermal Delivery System for the Anti-Inflammatory Lumiracoxib: Influence of Oleic Acid on In Vitro Percutaneous Absorption and In Vivo Potential Cutaneous Irritation
Tailane Sant'Anna Moreira et al.
AAPS PHARMSCITECH (2010)
The anti-proliferative potency of celecoxib is not a class effect of coxibs
Susanne Schiffmann et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Development and validation of HPLC method for imiquimod determination in skin penetration studies
Daniel De Paula et al.
BIOMEDICAL CHROMATOGRAPHY (2008)
Transdermal delivery of ketoprofen: The influence of drug-dioleylphosphatidylcholine interactions
Maria Teresa Junqueira Garcia et al.
PHARMACEUTICAL RESEARCH (2006)
Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: Characterization and study of in vitro and in vivo delivery
Luciana B. Lopes et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2006)
Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy
MBR Pierre et al.
PHARMACEUTICAL RESEARCH (2006)
Determination of celecoxib in human plasma and breast milk by high-performance liquid chromatographic assay
M Zhang et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices
RN Rao et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2005)
Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin
R Steluti et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2005)
Determination of celecoxib in human plasma using solid-phase extraction and high-performance liquid chromatography
HHS Chow et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2004)
Isolation, synthesis and characterization of impurities in Celecoxib a cox-2 inhibitor
U Satyanarayana et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2004)
Determination of celecoxib in human plasma by high-performance liquid chromatography
H Jalalizadeh et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2004)
Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention
K Kismet et al.
CANCER DETECTION AND PREVENTION (2004)
Simultaneous determination of celecoxib, hydroxycelecoxib, and carboxycelecoxib in human plasma using gradient reversed-phase liquid chromatography with ultraviolet absorbance detection
E Störmer et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Determination of celecoxib in pharmaceutical formulations using UV spectrophotometry and liquid chromatography
RN Saha et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2002)
Simple and sensitive method for the determination of celecoxib in human serum by high-performance liquid chromatography with fluorescence detection
F Schönberger et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
A stability-indicating HPLC method to determine celecoxib in capsule formulations
PM Dhabu et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2002)
Determination of celecoxib in human plasma and rat microdialysis samples by liquid chromatography tandem mass spectrometry
L Bräutigam et al.
JOURNAL OF CHROMATOGRAPHY B (2001)
Liquid chromatographic-mass spectrometric determination of celecoxib in plasma using single-ion monitoring and its use in clinical pharmacokinetics
M Abdel-Hamid et al.
JOURNAL OF CHROMATOGRAPHY B (2001)
Share Paper
